Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HDAC1 | Q13547 | 4/20 | 0.36 |
| ▸ | HDAC8 | Q9BY41 | 3/20 | 0.36 |
| ▸ | CTSK | P43235 | 4/20 | 0.35 |
| ▸ | HDAC4 | P56524 | 2/20 | 0.35 |
| ▸ | BCHE | P06276 | 1/20 | 0.35 |
| ▸ | ACHE | P22303 | 1/20 | 0.35 |
| ▸ | HDAC3 | O15379 | 1/20 | 0.34 |
| ▸ | HDAC7 | Q8WUI4 | 1/20 | 0.34 |
| ▸ | HDAC2 | Q92769 | 1/20 | 0.34 |
| ▸ | HDAC10 | Q969S8 | 1/20 | 0.34 |
| ▸ | HDAC11 | Q96DB2 | 1/20 | 0.34 |
| ▸ | HDAC6 | Q9UBN7 | 1/20 | 0.34 |
| ▸ | HDAC9 | Q9UKV0 | 1/20 | 0.34 |
| ▸ | HDAC5 | Q9UQL6 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1490123 | 0.98 | HDAC1 (0.36) | HDAC1HDAC8CTSKHDAC4HDAC3 | |
| SCHEMBL1490120 | 0.98 | HDAC1 (0.36) | HDAC1HDAC8CTSKHDAC4HDAC3 | |
| SCHEMBL1490122 | 0.98 | HDAC1 (0.36) | HDAC1HDAC8CTSKHDAC4HDAC3 | |
| SCHEMBL2541221 | 0.93 | HDAC1 (0.37) | HDAC1HDAC8CTSKHDAC4HDAC3 | |
| SCHEMBL1487490 | 0.93 | HDAC1 (0.37) | HDAC1HDAC8CTSKHDAC4HDAC3 | |
| SCHEMBL2543519 | 0.92 | HDAC1 (0.38) | HDAC1HDAC8CTSKHDAC4HDAC3 | |
| SCHEMBL2537720 | 0.92 | HDAC1 (0.38) | HDAC1HDAC8CTSKHDAC4HDAC3 | |
| SCHEMBL1937063 | 0.92 | HDAC1 (0.38) | HDAC1HDAC8CTSKHDAC4HDAC3 | |
| SCHEMBL2537724 | 0.92 | HDAC1 (0.38) | HDAC1HDAC8CTSKHDAC4HDAC3 | |
| SCHEMBL2537722 | 0.92 | HDAC1 (0.38) | HDAC1HDAC8CTSKHDAC4HDAC3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2331553-A1 | HEPATITIS C VIRUS INHIBITORS | Bristol-Myers Squibb Company (US) | 2011-06-15 | — | — | EP | disclosed |
| WO-2010036896-A1 | HEPATITIS C VIRUS INHIBITORS | BRISTOL-MYERS SQUIBB COMPANY (US) | 2010-04-01 | — | — | WO | disclosed |